Ebola: The Biopharm Industry Committed to Advancements

To download the full report, click here.

Researchers around the world, from both the public and private sectors, are increasingly working collaboratively to develop new ways to prevent the spread of Ebola and treat patients who have contracted the virus. The research and development process for new medicines is a lengthy, challenging and complex process, which is more often than not fraught with scientific setbacks. On average it takes 10-15 years and $2.6 billion to develop a new medicine. Biopharmaceutical researchers are working to compress that timeline for Ebola projects in their pipelines.